DR. WASIF RIAZ M.D NPI 1497929319

NPI Information

  • NPI: 1497929319
  • Provider Name: DR. WASIF RIAZ, M.D
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4420 SUN N LAKE BLVD
    SEBRING, FL
    ZIP 33872
  • Phone: (863) 385-1244

Map and Directions

Get Directions

NPI Details

DR. Wasif Riaz, M.D is a medical oncology internal medicine in Sebring, FL with 25 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Wasif Riaz, M.D NPI is 1497929319. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

4420 SUN N LAKE BLVD
SEBRING, FL
ZIP 33872-164
Phone: (863) 385-1244
Fax: (863) 385-6086

The NPI 1497929319 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Iron level (HCPCS:83540)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Magnesium level (HCPCS:83735)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Folic acid level, serum (HCPCS:82746)
  • Iron binding capacity (HCPCS:83550)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Automated urinalysis test (HCPCS:81003)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Urinalysis, manual test (HCPCS:81002)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)

The enumeration date for this NPI number is 4/22/2008 and was last updated on 8/17/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyME119193FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.